Finch Therapeutics Group (FNCH) Stock Chart & Stock Price History $13.48 +1.45 (+12.05%) As of 08/21/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Finch Therapeutics Group Stock Price Performance The Finch Therapeutics Group (FNCH) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 19.72%, with a year-to-date return of 19.29%. In the past month, the stock has increased 8.80%, reflecting recent market activity. As of the latest close, Finch Therapeutics Group traded at $13.48 with a market cap of $21.65 million and volume of 15,888 shares. Receive FNCH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.14%1 Month Performance+8.80%3 Month Performance+3.69%Year-To-Date Performance+19.29%1 Year Performance+19.72% FNCH Stock Chart for Friday, August, 22, 2025 FNCH Chart by TradingView Finch Therapeutics Group Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$12.03$13.48+12.05%$13.50$11.7715,888 shs$21.65 million08/20/2025$12.50$12.03-3.76%$12.03$12.03101 shs$19.32 million08/19/2025$12.70$12.50-1.57%$13.79$12.0017,905 shs$20.08 million08/18/2025$12.70$12.70$12.70$12.683,026 shs$20.40 million08/15/2025$12.74$12.70-0.31%$12.70$12.683,026 shs$20.40 million08/14/2025$12.15$12.74+4.86%$12.75$12.145,140 shs$20.46 million08/13/2025$12.25$12.15-0.82%$12.19$12.15670 shs$19.51 million08/12/2025$12.24$12.25+0.08%$12.25$12.25436 shs$19.67 million08/11/2025$12.45$12.24-1.65%$12.24$12.00489 shs$19.66 million08/08/2025$12.45$12.45$12.45$11.972,622 shs$19.99 million Get the Latest News and Ratings for FNCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$12.43$12.45+0.12%$12.45$11.972,622 shs$19.99 million08/06/2025$12.29$12.43+1.14%$12.43$11.74985 shs$19.96 million08/05/2025$12.29$12.29$12.29$11.502,254 shs$19.74 million08/04/2025$12.47$12.29-1.44%$12.29$11.502,254 shs$20.02 million08/01/2025$12.03$12.47+3.66%$12.47$12.47253 shs$20.03 million07/31/2025$12.50$12.03-3.76%$12.03$12.03280 shs$19.32 million07/30/2025$12.50$12.50$12.50$12.002,049 shs$20.08 million07/29/2025$12.50$12.50$12.56$12.50723 shs$20.08 million07/28/2025$12.55$12.50-0.40%$12.56$12.50723 shs$20.08 million07/25/2025$12.50$12.55+0.40%$12.55$12.55805 shs$20.16 million07/24/2025$12.28$12.50+1.79%$12.70$12.501,328 shs$20.08 million07/23/2025$12.39$12.28-0.89%$12.73$12.28743 shs$19.72 million07/22/2025$12.29$12.39+0.81%$12.39$12.023,586 shs$19.90 million07/21/2025$12.50$12.29-1.68%$12.43$12.252,402 shs$19.74 million Related Companies IGMS Stock Price Chart AVTE Stock Price Chart CELU Stock Price Chart JMAC Stock Price Chart QNTM Stock Price Chart PMVP Stock Price Chart ASRT Stock Price Chart FBRX Stock Price Chart IOBT Stock Price Chart ZIVO Stock Price Chart Receive FNCH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FNCH) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Finch Therapeutics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Finch Therapeutics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access